Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group. [electronic resource]
Producer: 20200310Description: E183-E185 p. digitalISSN:- 1096-8652
- Adenine -- analogs & derivatives
- Autoimmune Diseases -- drug therapy
- Disease-Free Survival
- Female
- Hematologic Diseases -- drug therapy
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Piperidines
- Purines -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
- Quinazolinones -- administration & dosage
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Letter; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.